Scleroderma mimics – Clinical features and management
Systemic sclerosis is a severe immune-mediated rheumatic disease by virtue of its clinical impact and mortality. There are a number of other sclerosing skin diseases that should be considered in the differential diagnosis and these are important because they may require specialist investigation and...
Gespeichert in:
| Veröffentlicht in: | Best practice & research. Clinical rheumatology 2020-02, Vol.34 (1), p.101489-101489, Article 101489 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 101489 |
|---|---|
| container_issue | 1 |
| container_start_page | 101489 |
| container_title | Best practice & research. Clinical rheumatology |
| container_volume | 34 |
| creator | Orteu, Catherine H. Ong, Voon H. Denton, Christopher P. |
| description | Systemic sclerosis is a severe immune-mediated rheumatic disease by virtue of its clinical impact and mortality. There are a number of other sclerosing skin diseases that should be considered in the differential diagnosis and these are important because they may require specialist investigation and management. In addition, long-term follow up of the different conditions should reflect the risk of associated complications and anticipated duration of therapy. This article reviews the clinical features of potential mimics of scleroderma (systemic sclerosis) including localised forms of scleroderma (morphoea) and other conditions that lead to skin thickening and connective tissue fibrosis or scarring. |
| doi_str_mv | 10.1016/j.berh.2020.101489 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2375503238</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1521694220300061</els_id><sourcerecordid>2375503238</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-a34e25f8af000052dd2d87472f26fd2a9147d88ee7db1ddf9af1efac8c2d84b13</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMoznh5ARfSpZuOubRNCm5k8AYDLtR1SJMTzdC0Y9IK7nwH39AnsbWjS7NJCN__c86H0AnBC4JJcb5eVBBeFhTTn49MlDtoTnJGU8I53h3flKRFmdEZOohxjTFjJc320YxRknEmijniD7qG0BoIXiXeeadj8vXxmSxr1zit6sSC6voAMVGNSbxq1DN4aLojtGdVHeF4ex-ip-urx-Vturq_uVterlKdYdylimVAcyuUxcPJqTHUCJ5xamlhDVXlMIcRAoCbihhjS2UJWKWFHrisIuwQnU29m9C-9hA76V3UUNeqgbaPkjKe55hRJgaUTqgObYwBrNwE51V4lwTLUZhcy1GYHIXJSdgQOt3295UH8xf5NTQAFxMAw5ZvDoKM2kGjwbgAupOmdf_1fwNRU3yO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2375503238</pqid></control><display><type>article</type><title>Scleroderma mimics – Clinical features and management</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Orteu, Catherine H. ; Ong, Voon H. ; Denton, Christopher P.</creator><creatorcontrib>Orteu, Catherine H. ; Ong, Voon H. ; Denton, Christopher P.</creatorcontrib><description>Systemic sclerosis is a severe immune-mediated rheumatic disease by virtue of its clinical impact and mortality. There are a number of other sclerosing skin diseases that should be considered in the differential diagnosis and these are important because they may require specialist investigation and management. In addition, long-term follow up of the different conditions should reflect the risk of associated complications and anticipated duration of therapy. This article reviews the clinical features of potential mimics of scleroderma (systemic sclerosis) including localised forms of scleroderma (morphoea) and other conditions that lead to skin thickening and connective tissue fibrosis or scarring.</description><identifier>ISSN: 1521-6942</identifier><identifier>EISSN: 1532-1770</identifier><identifier>DOI: 10.1016/j.berh.2020.101489</identifier><identifier>PMID: 32147386</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Fasciitis ; Graft versus host disease ; Morphoea ; Nephrogenic systemic fibrosis ; Raynaud's phenomenon ; Scleroderma ; Scleromyxoedema ; Systemic sclerosis</subject><ispartof>Best practice & research. Clinical rheumatology, 2020-02, Vol.34 (1), p.101489-101489, Article 101489</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-a34e25f8af000052dd2d87472f26fd2a9147d88ee7db1ddf9af1efac8c2d84b13</citedby><cites>FETCH-LOGICAL-c400t-a34e25f8af000052dd2d87472f26fd2a9147d88ee7db1ddf9af1efac8c2d84b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.berh.2020.101489$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32147386$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Orteu, Catherine H.</creatorcontrib><creatorcontrib>Ong, Voon H.</creatorcontrib><creatorcontrib>Denton, Christopher P.</creatorcontrib><title>Scleroderma mimics – Clinical features and management</title><title>Best practice & research. Clinical rheumatology</title><addtitle>Best Pract Res Clin Rheumatol</addtitle><description>Systemic sclerosis is a severe immune-mediated rheumatic disease by virtue of its clinical impact and mortality. There are a number of other sclerosing skin diseases that should be considered in the differential diagnosis and these are important because they may require specialist investigation and management. In addition, long-term follow up of the different conditions should reflect the risk of associated complications and anticipated duration of therapy. This article reviews the clinical features of potential mimics of scleroderma (systemic sclerosis) including localised forms of scleroderma (morphoea) and other conditions that lead to skin thickening and connective tissue fibrosis or scarring.</description><subject>Fasciitis</subject><subject>Graft versus host disease</subject><subject>Morphoea</subject><subject>Nephrogenic systemic fibrosis</subject><subject>Raynaud's phenomenon</subject><subject>Scleroderma</subject><subject>Scleromyxoedema</subject><subject>Systemic sclerosis</subject><issn>1521-6942</issn><issn>1532-1770</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKxDAUhoMoznh5ARfSpZuOubRNCm5k8AYDLtR1SJMTzdC0Y9IK7nwH39AnsbWjS7NJCN__c86H0AnBC4JJcb5eVBBeFhTTn49MlDtoTnJGU8I53h3flKRFmdEZOohxjTFjJc320YxRknEmijniD7qG0BoIXiXeeadj8vXxmSxr1zit6sSC6voAMVGNSbxq1DN4aLojtGdVHeF4ex-ip-urx-Vturq_uVterlKdYdylimVAcyuUxcPJqTHUCJ5xamlhDVXlMIcRAoCbihhjS2UJWKWFHrisIuwQnU29m9C-9hA76V3UUNeqgbaPkjKe55hRJgaUTqgObYwBrNwE51V4lwTLUZhcy1GYHIXJSdgQOt3295UH8xf5NTQAFxMAw5ZvDoKM2kGjwbgAupOmdf_1fwNRU3yO</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Orteu, Catherine H.</creator><creator>Ong, Voon H.</creator><creator>Denton, Christopher P.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200201</creationdate><title>Scleroderma mimics – Clinical features and management</title><author>Orteu, Catherine H. ; Ong, Voon H. ; Denton, Christopher P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-a34e25f8af000052dd2d87472f26fd2a9147d88ee7db1ddf9af1efac8c2d84b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Fasciitis</topic><topic>Graft versus host disease</topic><topic>Morphoea</topic><topic>Nephrogenic systemic fibrosis</topic><topic>Raynaud's phenomenon</topic><topic>Scleroderma</topic><topic>Scleromyxoedema</topic><topic>Systemic sclerosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Orteu, Catherine H.</creatorcontrib><creatorcontrib>Ong, Voon H.</creatorcontrib><creatorcontrib>Denton, Christopher P.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Best practice & research. Clinical rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Orteu, Catherine H.</au><au>Ong, Voon H.</au><au>Denton, Christopher P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Scleroderma mimics – Clinical features and management</atitle><jtitle>Best practice & research. Clinical rheumatology</jtitle><addtitle>Best Pract Res Clin Rheumatol</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>34</volume><issue>1</issue><spage>101489</spage><epage>101489</epage><pages>101489-101489</pages><artnum>101489</artnum><issn>1521-6942</issn><eissn>1532-1770</eissn><abstract>Systemic sclerosis is a severe immune-mediated rheumatic disease by virtue of its clinical impact and mortality. There are a number of other sclerosing skin diseases that should be considered in the differential diagnosis and these are important because they may require specialist investigation and management. In addition, long-term follow up of the different conditions should reflect the risk of associated complications and anticipated duration of therapy. This article reviews the clinical features of potential mimics of scleroderma (systemic sclerosis) including localised forms of scleroderma (morphoea) and other conditions that lead to skin thickening and connective tissue fibrosis or scarring.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>32147386</pmid><doi>10.1016/j.berh.2020.101489</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1521-6942 |
| ispartof | Best practice & research. Clinical rheumatology, 2020-02, Vol.34 (1), p.101489-101489, Article 101489 |
| issn | 1521-6942 1532-1770 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2375503238 |
| source | ScienceDirect Journals (5 years ago - present) |
| subjects | Fasciitis Graft versus host disease Morphoea Nephrogenic systemic fibrosis Raynaud's phenomenon Scleroderma Scleromyxoedema Systemic sclerosis |
| title | Scleroderma mimics – Clinical features and management |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T13%3A10%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Scleroderma%20mimics%20%E2%80%93%20Clinical%20features%20and%20management&rft.jtitle=Best%20practice%20&%20research.%20Clinical%20rheumatology&rft.au=Orteu,%20Catherine%20H.&rft.date=2020-02-01&rft.volume=34&rft.issue=1&rft.spage=101489&rft.epage=101489&rft.pages=101489-101489&rft.artnum=101489&rft.issn=1521-6942&rft.eissn=1532-1770&rft_id=info:doi/10.1016/j.berh.2020.101489&rft_dat=%3Cproquest_cross%3E2375503238%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2375503238&rft_id=info:pmid/32147386&rft_els_id=S1521694220300061&rfr_iscdi=true |